NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Journal of Acquired Immune Deficiency Syndromes - JAIDS Année : 2013

NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers

Résumé

NKG2D mediates an important costimulatory pathway in CD8 T cells. In HIV infection, the authors found that NKG2D expression on both total CD8 and HIV-specific CD8 T cells was significantly lower in viremic patients than in HIV controllers. Antiretroviral therapy partially restored NKG2D expression on HIV-specific CD8 T cells. The authors observed a negative correlation between the respective expression levels of CD38 and NKG2D on total CD8 and HIV-specific CD8 T cells. The maintenance of NKG2D expression on CD8 T cells in HIV controllers may contribute to better cell function.
Fichier principal
Vignette du fichier
JAIDS Lambotte NKG2D revised.pdf (113.19 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

pasteur-01420533 , version 1 (16-05-2017)

Licence

Identifiants

Citer

Camille Lecuroux, Asier Saez-Cirion, Nicolas Noel, Lilia Ben-Lamine, Isabelle Girault, et al.. NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers. Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2013, 62 (1), pp.17--20. ⟨10.1097/QAI.0b013e318274579f⟩. ⟨pasteur-01420533⟩
382 Consultations
377 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More